Home
Conditions
Lung Neoplasms

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,211 public trials 1,007 recruiting studies

Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Recruiting

Cancer-related Fatigue During Maintenance Immunotherapy for Non-small Cell Lung Cancer (NSCLC): a Qualitative Study

NCT06567704

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Atrium Health Levine Cancer Charlotte, North Carolina, United States

Wake Forest Baptist Comprehensive Cancer Center Winston-Salem, North Carolina, United States

View Trial Details

Recruiting

Intrathecal Pemetrexed for Leptomeningeal Metastasis From Lung Adenocarcinoma That Progressed After Osimertinib.

NCT06296745

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more
Locations: The Affiliated Huizhou Hospital, Guangzhou Medical University Huizhou, Guangdong, China

View Trial Details

Recruiting

[177Lu]Lu-AKIR001 First-in-human Study

NCT06639191

Conditions: Bronchial Neoplasms, Cancer Head and Neck, Carcinoma, +31 more
Locations: Karolinska University hospital Stockholm, Stockholm County, Sweden

View Trial Details

Recruiting

Cryoablation in Combination (or Not) With Pembrolizumab and Pemetrexed-carboplatin in 1st-line Treatment for Patients With Metastatic Lung Adenocarcinoma

NCT04339218

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Carcinoma, +9 more
Locations: Institut Bergonié Bordeaux, Gironde, France

View Trial Details

Recruiting

A Phase 1 Study of TGI-5 as Monotherapy and in Combination With Nivolumab in Subjects With Locally Advanced/Metastatic Solid Tumors

NCT07376707

Conditions: Adenocarcinoma, Bronchial Neoplasms, CRC (Colorectal Cancer), +36 more
Locations: Fudan University Shanghai Cancer Center Shanghai, China

View Trial Details

Recruiting

Iruplinalkib in ALK-Positive Advanced Lung Adenocarcinoma After Lorlatinib

NCT07374614

Conditions: ALK, Bronchial Neoplasms, Carcinoma, Bronchogenic, +13 more
Locations: Peking University Shenzhen Hospital Shenzhen, Guangdong, China

View Trial Details

Recruiting

An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors

NCT07371663

Conditions: Ataxia, Ataxia Telangiectasia, Brain Diseases, +60 more
Locations: Beijing Cancer Hospital Beijing, Beijing Municipality, China

Henan Cancer Hospital Zhengzhou, Henan, China

Zhejiang Cancer Hospital Hangzhou, Zhejiang, China

View Trial Details

Recruiting

Smoking Cessation Before Bronchoscopy or CT-guided Puncture

NCT07322796

Conditions: Behavior, Health Behavior, Lung Diseases, +12 more
Locations: University RWTH Aachen Aachen, North Rhine-Westphalia, Germany

View Trial Details

Recruiting

A Prospective, Single-Arm, Single-Center Phase II Study Evaluating the Efficacy and Safety of Chidamide Combined With PD-L1 Inhibitor, Carboplatin, and Etoposide as First-Line Treatment in Patients With Extensive-Stage Small-Cell Lung Cancer (ES-SCLC)

NCT07373964

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations: The First Affiliated Hospital of China Medical University Shenyang, Liaoning, China

View Trial Details

Recruiting

Combination of Atezolizumab and Pirfenidone in Second-line and Beyond NSCLC

NCT04467723

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more
Locations: The University of Kansas Cancer Center (KUCC) Fairway, Kansas, United States

The University of Kansas Cancer Center, Westwood Campus Kansas City, Kansas, United States

View Trial Details

Lung Neoplasms

Lung Neoplasms trial results

Related conditions